FibroGen Inc
NASDAQ:KYNB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
FibroGen Inc
NASDAQ:KYNB
|
US |
|
S
|
Sekisui Chemical Co Ltd
SWB:SUI
|
JP |
|
Airbnb Inc
NASDAQ:ABNB
|
US |
|
Verisign Inc
NASDAQ:VRSN
|
US |
|
M
|
MGM Resorts International
XMUN:MGG
|
US |
|
K
|
Kellogg Co
LSE:0R1R
|
US |
|
I
|
ImmunoGen Inc
XBER:IMU
|
US |
|
G
|
Gemfields Group Ltd
JSE:GML
|
GG |
|
A
|
Abercrombie & Fitch Co
DUS:AFT
|
US |
|
Datatec Ltd
F:DTT0
|
ZA |
|
F
|
Fortinet Inc
F:FO8
|
US |
|
B
|
British American Tobacco PLC
JSE:BTI
|
UK |
|
I
|
Impianti SpA
MIL:MPT
|
IT |
|
Visteon Corp
NASDAQ:VC
|
US |
|
Delek US Holdings Inc
NYSE:DK
|
US |
|
G
|
Genus PLC
OTC:GENSF
|
UK |
|
Carnival PLC
LSE:CCL
|
UK |
|
Alimentation Couche-Tard Inc
TSX:ATD
|
CA |
|
C
|
Capitec Bank Holdings Ltd
JSE:CPI
|
ZA |
Bankruptcy Probability
FibroGen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
FibroGen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
FibroGen Inc
NASDAQ:FGEN
|
32.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
447.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
193.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
158.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
FibroGen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, FibroGen Inc has total debt of 19.5m USD. This includes both short-term (0 USD) and long-term (19.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
